# FDA Rejected MDMA for PTSD. Now It Wants the Sequel to Succeed.

- slug: fda-rejected-mdma-for-ptsd-now-it-wants-the-sequel-to-succeed
- date: 2026-04-24
- category: Biotech & Life Sciences

A methylone pill for PTSD showed a 9.64-point improvement over placebo in Phase 2 — and the FDA just fast-tracked it with a priority review voucher, after rejecting the last psychedelic PTSD drug in 2024 for trial design flaws.

---